These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2874569

  • 1. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Hara C, Kastin AJ.
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
    [Abstract] [Full Text] [Related]

  • 2. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ, Wei ET.
    Peptides; 1984 Jun; 5(5):883-7. PubMed ID: 6150468
    [Abstract] [Full Text] [Related]

  • 3. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
    Kostrzewa RM, Kastin AJ.
    Brain Res Bull; 1993 Jun; 31(6):707-12. PubMed ID: 8100182
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ, Bhargava HN, Wei ET.
    Peptides; 1987 Jun; 8(6):1051-5. PubMed ID: 2894644
    [Abstract] [Full Text] [Related]

  • 5. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN, Kim HS.
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [Abstract] [Full Text] [Related]

  • 6. The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat.
    Bhargava HN.
    Life Sci; 1981 Jul 06; 29(1):45-51. PubMed ID: 6115301
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN, Kim HS.
    Neuropharmacology; 1982 Sep 06; 21(9):917-22. PubMed ID: 6128692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK.
    Neuropeptides; 1991 Aug 06; 19(4):281-5. PubMed ID: 1681456
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats.
    Hayashi T, Kastin AJ, Coy DH, Olson RD.
    Brain Res Bull; 1983 Dec 06; 11(6):659-62. PubMed ID: 6140994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Central administration of Tyr-MIF-1 stimulates gastrointestinal motility in rats: evidence for the involvement of dopamine, sigma and CCK receptors.
    Million M, Fioramonti J, Bueno L.
    Neuropeptides; 1994 Feb 06; 26(2):77-85. PubMed ID: 7909585
    [Abstract] [Full Text] [Related]

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D, Watanabe C, Watanabe H, Mizoguchi H, Sakurada T, Sakurada S.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):109-16. PubMed ID: 17343845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.